Oncotype DX was utilized on FFPE tumor samples from 651 patients out of 2,306 ER +ve and LN –ve BCA patients enlisted in the NSABP-20 trial, the first validation study for this assay’s the predictive component (17). Here, ESR1 is linked to neoplasm.